Justin Koepsel, Ph.D, M.B.A

Senior Director, Commercial Operations

Catalent Biologics, Drug Substance

Dr. Koepsel has over 10 years of experience in the biotech industry in various technical and business roles. Since joining Catalent Biologics in 2021, he has been leading Catalent’s Commercial Operations team managing Protein and mRNA Drug Substance Clients across the Catalent network in Madison, WI, and Bloomington, IN. His team works in close collaboration with the business development and site operations teams supporting contractual and business needs for clients, driving process improvements for the business, and forecasting short- and long-term demand for each site. Prior to joining Catalent, Dr. Koepsel served as Chief of Staff for Vyriad Inc., Technology Development Manager at Mayo Clinic Ventures, Operations Manager at Stratatech Corporation (now Mallinckrodt), and Engineer at Kensey Nash Corporation (now DSM Biomedical). Dr. Koepsel received a BS in Materials Science from The Ohio State University, a PhD in Biomedical Engineering from the University of Wisconsin-Madison, and an MBA from the University of Minnesota, Duluth.